STATEMENTS OF CASH FLOW (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
OPERATING ACTIVITIES:
Net loss	$ (669,409)	$ (1,459,146)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment expense		200,000
Inventory write down	14,402
Common stock issued for services	372,725	925,679
Amortization of note discount	100,098	172,972
Loss on conversion of debt	14,562	21,000
Change in assets and liabilities
(Increase) decrease in inventory	10,477	(24,879)
(Increase) in prepaids
Increase in accounts payable and accrued expenses	21,793	32,389
Total adjustments	534,057	1,327,161
Net cash used in operating activities	(135,352)	(131,985)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes and loans payable	139,512	134,220
Principal payments on notes and loans payable		(2,600)
Net cash provided by financing activities	139,512	131,620
NET INCREASE (DECREASE) IN CASH	4,160	(365)
CASH - BEGINNING OF PERIOD	711	1,076
CASH - END OF PERIOD	4,871	711
NONCASH OPERATING AND INVESTING ACTIVITIES:
Conversion of notes payable and accrued interest to common stock	54,788	131,765
Cancellation for 600,000 shares of common stock to settle liabilities	21,000
Conversion of liability to common stock		6,375
Acquisition of intellectual property of Glucose Health Natural Blood Sugar Maintenance product for common shares	$ 300